Kidney damage in the acute course of a new coronavirus infection and in the post-COVID period (Literature review)

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

Kidney damage is common in patients with COVID-19, which is associated with a poor prognosis. The causes and mechanisms of nephropathies, structural disorders, the course of acute kidney injury and chronic kidney disease in the acute phase of the disease, and renal disorders in the post-COVID period are considered. The features of the treatment of a new coronavirus infection in kidney diseases and the treatment of nephropathies in COVID-19 are presented. Attention is drawn to the constant monitoring of the nephrological safety of all prescribed drugs. Early rehabilitation can prevent kidney damage in the post-COVID period. This review highlights only part of the questions that the new coronavirus infection poses to the medical community. More research is needed to answer the many unresolved problems of kidney damage in COVID-19.

Full Text

Restricted Access

About the authors

O. A. Nagibovich

The S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation

Author for correspondence.
Email: olegnagibovich@mail.ru

доктор медицинских наук, доцент, полковник медицинской службы в отставке 

Russian Federation, St. Petersburg

D. A. Shipilova

The S.M.Kirov Military Medical Academy of the Ministry of Defense of the Russian Federation

Email: olegnagibovich@mail.ru

кандидат медицинских наук, капитан медицинской службы

Russian Federation, St. Petersburg

References

  1. Временные методические рекомендации «Профилактика, диагностика и лечение новой коронавирусной инфекции (COVID-19)». Версия 16 (18.08.2022 г.). – 248 с.
  2. Выхристенко Л.Р., Счастливенко А.И., Бондарева Л.И. и др. Поражение почек при инфекции COVID-19 // Вестн. Витебского гос. мед. ун-та. – 2021. – Т. 20, № 1. – С. 7–23.
  3. Клинические рекомендации. Острое повреждение почек. – 2020. – 142 с.
  4. Коган Е.А., Березовский Ю.С., Проценко Д.Д. и др. Патологическая анатомия инфекции, вызванной SARS-COV-2 // Судебная медицина. – 2020. – Т. 6, № 2. – С. 8–30.
  5. Методические материалы (проект). Об организации мероприятий по предупреждению распространения коронавирусной инфекции (2019-nCoV) в нефрологических (гемодиализных) центрах. – 2020. – 20 с.
  6. Методические рекомендации по организации работы программ заместительной почечной терапии методом перитонеального диализа при лечении пациентов с хронической болезнью почек 5 стадии в условиях распространения коронавирусной инфекции (2019-nCoV) (проект). – 2020. – 28 с.
  7. Столяревич Е.С., Фролова Н.Ф., Артюхина Л.Ю., Варясин В.В. Поражение почек при COVID-19: клинические и морфологические проявления почечной патологии у 220 пациентов, умерших от COVID-19 // Нефрология и диализ. – 2020. – Т. 22, № S. – С. 46–55.
  8. Фисун А.Я., Черкашин Д.В., Тыренко В.В. и др. Роль ренин-ангиотензин-альдостероновой системы во взаимодействии с коронавирусом SARS-CoV-2 и в развитии стратегий профилактики и лечения новой коронавирусной инфекции (COVID-19) // Артериальная гипертензия. – 2020. – Т. 26, № 3. – С. 248–262.
  9. Baig A.M., Khaleeq A., Ali U., Syeda H. Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms // ACS Chem. Neurosci. – 2020. – Vol. 11, N 7. – Р. 995–998.
  10. Basic-Jukic N., Juric I., Furic-Cunko V. et al. Follow-up of renal transplant recipients after acute COVID-19 – A prospective cohort single–center study // Immun. Inflamm. Dis. – 2021. – Vol. 9, N 4. – Р. 1563–1572.
  11. Bomback A.S., Canetta P.A., Ahn W. et al. How COVID-19 has changed the management of glomerular diseases // Clin. J. Am. Soc. Nephrol. – 2020. – Vol. 15, N 6. – P. 876–879.
  12. Bowe B., Xie Y., Xu E., Al-Aly Z. Kidney Outcomes in Long COVID// J. Am. Soc. Nephrol. – 2021. – Vol. 32, N 11. – Р. 2851–2862.
  13. Bruchfeld A. The COVID-19 pandemic: consequences for nephrology // Nat. Rev. Nephrol. – 2021. – Vol. 17, N 2. – Р. 81–82.
  14. Cheng Y., Luo R., Wang K. et al. Kidney disease is associated with in-hospital death of patients with COVID-19 // Kidney Int. – 2020. – Vol. 97, N 5. – Р. 829–838.
  15. Cheng Y., Wang W., Wu L., Cai G. SARS-CoV-2-Related Kidney Injury: Current Concern and Challenges // SN Comp. Clin. Med. – 2020. – Vol. 2, N 11. – Р. 2015–2024.
  16. Dennis A., Wamil M., Alberts J. et al. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study // BMJ Open. – 2021. – Vol. 11, N 3. – e048391.
  17. Diao B., Wang C., Wang R. et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection // Nat. Commun. – 2021.– Vol. 12, N 1.– Р. 2506.
  18. Gagliardi I., Patella G., Michael A. et al. COVID-19 and the kidney: from epidemiology to clinical practice // Clin. Med. – 2020. – Vol. 9, N 8. – Р. 2506.
  19. Guan W.J., Ni Z.Y., Hu Y. et al. Clinical characteristics of Coronavirus Disease 2019 in China // N. Engl. J. Med. – 2020. – Vol. 382, N 18. – P. 1708–1720.
  20. Hassanein M., Radhakrishnan Y., Sedor J. et al. COVID-19 and the kidney // Cleve Clin. J. Med. – 2020. – Vol. 87, N 10. – Р. 619–631.
  21. Huang C., Huang L., Wang Y. et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study // Lancet. – 2021. – Vol. 397, N 10270. – Р. 220–232.
  22. International Society of Nephrology (ISN) // URL: https://www.theisn.org/covid-19 (дата обращения 14.05.2021).
  23. Jager K.J., Kramer A., Chesnaye N.C. et al. Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe // Kidney Int. – 2020. – Vol. 98, N 6.– Р. 1540–1548.
  24. Khan S., Chen L., Yang C.R. et al. Does SARS-CoV-2 infect the kidney? // J. Am. Soc. Nephrol. – 2020. – Vol. 31, N 12. – Р. 2746–2748.
  25. Kidney disease improving global outcomes. KDIGO clinical practice guideline for acute kidney injury // Kidney Int. – 2012. – Vol. 2, N 1. – Р. 1–138.
  26. Kronbichler A., Gauckler P., Windpessl M. et al. COVID-19: implications for immunosuppression in kidney disease and transplantation // Nat. Rev. Nephrol. – 2020. – Vol. 16, N 7. – Р. 365–367.
  27. Mehraeen E., Karimib A., Barzegary A. et al. Predictors of mortality in patients with COVID-19 – a systematic review // Eur. J. Integr. Med. – 2020. – Vol. 40. – 101226.
  28. Moledina D.G., Simonov M., Yamamoto Y. et al. The association of COVID-19 with acute kidney injury independent of severity of illness: a multicenter cohort study // Am. J. Kidney Dis. – 2021. – Vol. 77, N 4. – Р. 490–499.
  29. Nadim M.K., Forni L.G., Mehta R.L. et al. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup // Nat. Rev. Nephrol. – 2020. – Vol. 16, N 12. – Р. 747–764.
  30. Nasr S.H., Alexander M.P., Cornell L.D. et al. Kidney biopsy findings in patients with COVID-19, kidney injury, and proteinuria // Am. J. Kidney Dis. – 2021. – Vol. 77, N 3. – Р. 465–468.
  31. Ng J.H., Hirsch J.S., Hazzan A. et al. Outcomes among patients hospitalized with COVID-19 and acute kidney injury // Am. J. Kidney Dis. – 2021. – Vol. 77, N 2. – Р. 204–215.
  32. Pan X.W., Xu D., Zhang H. et al. Identification of a potential mechanism of acute kidney injury during the COVID-19 outbreak: a study based on single-cell transcriptome analysis // Intens. Care Med. – 2020. – Vol. 46, N 6. – Р. 1114–1116.
  33. Recovery Collaborative Group, Horby P., Lim W.S. et al. Dexamethasone in Hospitalized Patients with COVID-19 – preliminary report // N. Engl. J. Med. – 2021. – Vol. 384, N 8. – Р. 693–704.
  34. Ribeiro H.S., Rodrigues A.E., Cantuбria J. et al. Post-COVID-19 rehabilitation: a special look at chronic kidney disease patients // Ren Replace Ther. – 2021. – Vol. 7, N 1. – Р. 33.
  35. Ronco C., Reis T., Husain-Syed F. Management of acute kidney injury in patients with COVID-19 // Lancet Respir. Med. – 2020. – Vol. 8, Iss. 7 . – Р. 738–742.
  36. Silver S.A., Beaubien-Souligny W., Shah P.S. et al. The prevalence of acute kidney injury in patients hospitalized with COVID-19 infection: a systematic review and meta-analysis // Kidney Med. – 2021. – Vol. 3, N 1. – Р. 83–98.
  37. Su H., Yang M., Wan C. et al. Renal histopathological analysis of 26 postmortem findings of patients with COVID-19 in China // Kidney Int. – 2020.– Vol. 98, N 1. – Р. 219–227.
  38. Williamson E.J., Walker A.J., Bhaskaran K. et al. Factors associated with COVID-19-related death using OpenSAFELY // Nature. – 2020. – Vol. 584, N 7821. – Р. 430–436.
  39. Yang X., Yu Y., Xu J. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study // Lancet Respir. Med. – 2020. – Vol. 8, N 5. – Р. 475–481.
  40. Yende S., Parikh C.R. Long COVID and kidney disease // Nat. Rev. Nephrol. – 2021. – Vol. 17, N 12. – Р. 792–793.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2023 Nagibovich O.A., Shipilova D.A.


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: № 01975 от 30.12.1992.